Thromb Haemost 2016; 116(05): 1001
DOI: 10.1160/TH16-05-0396
Author Correspondence
Schattauer GmbH

The ERIKA trial: still limited evidence on the efficacy of thromboprophylaxis after knee arthroscopy

Banne Nemeth
1   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
2   Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands
,
Raymond A. van Adrichem
1   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
2   Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands
,
Suzanne C. Cannegieter
1   Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
3   Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received: 24 May 2016

Accepted after major revision: 07 June 2016

Publication Date:
30 November 2017 (online)

 

 
  • References

  • 1 Camporese G, Bernardi E, Noventa F. et al. Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA). A phase II, multicentre, double-blind, placebo-controlled randomised study. Thromb Haemost 2016; 116: 349-355.
  • 2 Gaskill T, Pullen M, Bryant B. et al. The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction. Am JSports Med 2015; 43: 2714-2719.
  • 3 Krych AJ, Sousa PL, Morgan JA. et al. Incidence and Risk Factor Analysis of Symptomatic Venous Thromboembolism After Knee Arthroscopy. Arthroscopy 2015 Epub ahead of print.
  • 4 Mauck KF, Froehling DA, Daniels PR. et al. Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study. JThrombHaemost 2013; 11: 1279-1286.